Related Experiment Video

Updated: May 22, 2026

The Intra-Aortic Balloon Pump
06:13

The Intra-Aortic Balloon Pump

Published on: February 5, 2021

[Clinical application of intra-aortic balloon pump in patients with serious cardiovascular diseases]

Qiong Xie1, Ying Guo, Hongwei Pan

  • 1Department of Cardiology, Hunan Provincial People's Hospital, Changsha 410005, China.

Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences
|May 8, 2012
PubMed

Insights

Intra-aortic balloon pumps (IABP) effectively treat serious cardiovascular diseases, improving patient vitals and reducing cardiac events. This study found IABP to be a safe and beneficial early intervention for critical cardiac patients.

Area of Science:

  • Cardiovascular Medicine
  • Medical Devices
  • Critical Care

Context:

  • Serious cardiovascular diseases pose significant risks.
  • Intra-aortic balloon pumps (IABP) are used for hemodynamic support.
  • Evaluating IABP's role in critical cardiac care is essential.

Purpose:

  • To assess the therapeutic efficacy and safety of intra-aortic balloon pumps (IABP) in patients with severe cardiovascular conditions.
  • To analyze the impact of IABP on key physiological parameters and clinical outcomes.

Summary:

  • A retrospective analysis of 68 patients with serious cardiovascular diseases receiving IABP support was conducted.
  • IABP therapy led to significant improvements in systolic and diastolic blood pressure, heart rate, and NT-proBNP levels.
  • The study observed positive clinical outcomes, including successful percutaneous coronary intervention in 37 patients, with only minor complications.

Impact:

  • IABP demonstrates effectiveness and safety in managing critical cardiovascular patients.
  • Early application of IABP is recommended for patients with appropriate indications.
  • This supports the integration of IABP as a valuable tool in critical cardiovascular care pathways.
Abstract

More Related Videos

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...